Immunome Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Immunome Inc's ROI in the second quarter of 2026?
Immunome Inc recorded a cumulative net loss of $-254 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -50.16%.

Within the Healthcare sector 473 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2929 to 3752.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	102.62 %	80.55 %	60.68 %	20.05 %	36.54 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	530	592	638	268	273
Return On Investment (TTM)	-50.16 %	-50.7 %	-56.26 %	-84.53 %	-84.87 %
IMNM's Overall Ranking	# 3752	# 2929	# 2909	# 3471	# 3662
Seq. Investment Change TTM	14.46 %	17.34 %	43.28 %	5.3 %	1.99 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-254	-225	-212	-223	-212

IMNM Company Profile >> Back to IMNM Roi Comparisons >> See Annual IMNM Return On Investment

Return On Investment IMNM's Ranking
Within:	No.
Industry	# 199
Sector	# 474
Overall	# 3752

Return On Investment Statistics
High	Average	Low
-24.92 %	-116.86 %	-509.47 %
(Jun 30 2021)		(Sep 30 2020)

Financial Statements
Immunome Inc's II. Quarter Investments	$ 530 Millions	IMNM's Balance sheet
Immunome Inc's II. Quarter Income	$ -73 Millions	Quarterly IMNM's Income Statement
IMNM's Income by Division		See IMNM's Income by Division

IMNM Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	638	182	120	17	48
Y / Y Investment Growth	250.52 %	51.46 %	619.2 %	-65.32 %	16.17 %
Net Income in Millions	-212	-293	-107	-38	-25
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-33.28 %	-160.9 %	-88.85 %	-224.46 %	-51.27 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IMNM's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for IMNM's Competitors
Subscribers only: Roi for Immunome Inc's Suppliers
Subscribers only: Return On Investment for IMNM's Customers

Other Ratios
IMNM's Roa	IMNM's Inventory Turnover Ratio	IMNM's Growth Rates	IMNM's Dividend Statistics
	IMNM's Profitability Ratios	IMNM's Asset Turnover Ratio	IMNM's Dividend Growth
IMNM's Roe	IMNM's Valuation Ratios	IMNM's Financial Strength Ratios	IMNM's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-05T00:07:35+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.